Bausch Health Companies Share Price (NYSE: BHC)

$8.04

▲

-0.3

(-3.6%)

Live

Last updated on August 18, 2025 at 11:45 PM IST

$₹

Check the interactive Bausch Health Companies Stock chart to analyse performance

Bausch Health Companies stock performance

as on August 18, 2025 at 11:45 PM IST

Today's Low:$8.00
Today's High:$8.42
$8.04
0.5%
Downside
Day's Volatility :4.99%
Upside
4.51%
52 Weeks Low:$4.25
52 Weeks High:$9.85
$8.04
47.14%
Downside
52 Weeks Volatility :56.85%
Upside
18.38%

Bausch Health Companies Stock Returns

Period	Bausch Health Companies Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	79.74%	2.3%	0.0%
6 Months	31.13%	-5.8%	0.0%
1 Year	45.04%	-10.9%	0.0%
3 Years	53.03%	2.8%	-11.6%

Bausch Health Companies Inc Key Stats

Check Bausch Health Companies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$8.34
Open	$7.95
Today's High	$8.42
Today's Low	$8.0
Market Capitalization	$3.1B
Today's Volume	$9.2M
52 Week High	$9.85
52 Week Low	$4.25
Revenue TTM	$9.9B
EBITDA	$3.1B
Earnings Per Share (EPS)	$0.26
PE Ratio	32.08
Profit Margin	0.99%
Quarterly Earnings Growth YOY	13.68%
Return On Equity TTM	-2304.54%

Stock Returns calculator for Bausch Health Companies Stock including INR - Dollar returns

The Bausch Health Companies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Bausch Health Companies investment value today

Current value as on today

₹1,43,900

Returns

₹43,900

(+43.9%)

Returns from Bausch Health Companies Stock

₹39,826 (+39.83%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Bausch Health Companies Stock

85%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Bausch Health Companies Stock from India on INDmoney has increased by 85% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Bausch Health Companies Inc

Name
Holdings %
Name
Holdings %
Nomura Holdings Inc
10.07%
ICAHN CARL C
9.39%
Paulson & Company Inc
8.87%
Goldentree Asset Management LP
8.18%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
3.52%
Vanguard Group Inc
3.18%

Analyst Recommendation on Bausch Health Companies Stock

Rating

Trend

Hold

0%Buy

60%Hold

40%Sell

Based on 10 Wall street analysts offering stock ratings for Bausch Health Companies(by analysts ranked 0 to 5 stars)

Bausch Health Companies Share Price Target

What analysts predicted

Downside of 11.9%

Target:

$7.08

Current:

$8.04

Bausch Health Companies share price target is $7.08, a slight Downside of 11.9% compared to current price of $8.04 as per analysts' prediction.

Bausch Health Companies Stock Insights

Price Movement
In the last 7 days, BHC stock has moved up by 25.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.22B → 2.50B (in $), with an average increase of 11.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -58.0M → 148.0M (in $), with an average increase of 139.2% per quarter
BHC vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 57.9% return, outperforming this stock by 12.9%

Bausch Health Companies Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$8.6B	↑ 2.64%
Net Income	$-1.8B	↓ 57.02%
Net Profit Margin	-20.73%	↑ 28.77%

	FY20	Y/Y Change
Revenue	$8.0B	↓ 6.67%
Net Income	$-559.0M	↓ 68.65%
Net Profit Margin	-6.96%	↑ 13.77%

	FY21	Y/Y Change
Revenue	$8.4B	↑ 5.07%
Net Income	$-937.0M	↑ 67.62%
Net Profit Margin	-11.11%	↓ 4.15%

	FY22	Y/Y Change
Revenue	$8.1B	↓ 3.68%
Net Income	$-212.0M	↓ 77.37%
Net Profit Margin	-2.61%	↑ 8.5%

	FY23	Y/Y Change
Revenue	$8.8B	↑ 7.79%
Net Income	$-592.0M	↑ 179.25%
Net Profit Margin	-6.76%	↓ 4.15%

	FY24	Y/Y Change
Revenue	$9.5B	↑ 8.69%
Net Income	$-43.8M	↓ 92.6%
Net Profit Margin	-0.46%	↑ 6.3%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$2.1B	↓ 10.99%
Net Income	$-63.7M	↓ 116.13%
Net Profit Margin	-2.97%	↓ 19.37%

	Q2 FY24	Q/Q Change
Revenue	$2.4B	↑ 12.09%
Net Income	$10.0M	↓ 115.7%
Net Profit Margin	0.42%	↑ 3.39%

	Q3 FY24	Q/Q Change
Revenue	$2.5B	↑ 4.47%
Net Income	$-85.0M	↓ 950.0%
Net Profit Margin	-3.39%	↓ 3.81%

	Q4 FY24	Q/Q Change
Revenue	$2.5B	↓ 1.91%
Net Income	$90.4M	↓ 206.32%
Net Profit Margin	3.67%	↑ 7.06%

	Q1 FY25	Q/Q Change
Revenue	$2.2B	↓ 9.55%
Net Income	$-58.0M	↓ 164.18%
Net Profit Margin	-2.6%	↓ 6.27%

	Q2 FY25	Q/Q Change
Revenue	$2.5B	↑ 12.44%
Net Income	$148.0M	↓ 355.17%
Net Profit Margin	5.91%	↑ 8.51%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$6.3B	↑ 3.68%

	FY20	Y/Y Change
Profit	$5.8B	↓ 7.57%

	FY21	Y/Y Change
Profit	$6.0B	↑ 4.53%

	FY22	Y/Y Change
Profit	$5.8B	↓ 4.64%

	FY23	Y/Y Change
Profit	$6.2B	↑ 7.6%

	FY24	Y/Y Change
Profit	$6.7B	↑ 8.68%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.2B	↓ 70.78%

	Q2 FY24	Q/Q Change
Profit	$1.4B	↑ 14.61%

	Q3 FY24	Q/Q Change
Profit	$1.5B	↑ 8.38%

	Q4 FY24	Q/Q Change
Profit	$1.7B	↑ 13.24%

	Q1 FY25	Q/Q Change
Profit	$1.5B	↓ 12.05%

	Q2 FY25	Q/Q Change
Profit	$2.5B	↑ 63.04%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.5B	↑ 0.0%
Investing Cash Flow	$-419.0M	↑ 113.78%
Financing Cash Flow	$1.4B	↓ 206.65%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↓ 25.98%
Investing Cash Flow	$-261.0M	↓ 37.71%
Financing Cash Flow	$-2.3B	↓ 258.97%

	FY21	Y/Y Change
Operating Cash Flow	$1.4B	↑ 28.35%
Investing Cash Flow	$409.0M	↓ 256.7%
Financing Cash Flow	$-1.5B	↓ 34.05%

	FY22	Y/Y Change
Operating Cash Flow	$-728.0M	↓ 151.05%
Investing Cash Flow	$-303.0M	↓ 174.08%
Financing Cash Flow	$-474.0M	↓ 68.67%

	FY23	Y/Y Change
Operating Cash Flow	$1.0B	↓ 241.76%
Investing Cash Flow	$-2.1B	↑ 607.92%
Financing Cash Flow	$1.5B	↓ 411.18%

	FY24	Y/Y Change
Operating Cash Flow	$1.6B	↑ 54.75%
Investing Cash Flow	$-454.0M	↓ 78.83%
Financing Cash Flow	$-868.0M	↓ 158.85%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$206.1M	↓ 47.16%
Investing Cash Flow	$-72.7M	↓ 50.9%
Financing Cash Flow	$-334.5M	↑ 323.42%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$378.7M	↑ 83.79%
Investing Cash Flow	$-79.0M	↑ 8.65%
Financing Cash Flow	$-423.4M	↑ 26.57%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$405.0M	↑ 6.93%
Investing Cash Flow	$-102.0M	↑ 29.18%
Financing Cash Flow	$-189.0M	↓ 55.36%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$601.0M	↑ 48.4%
Investing Cash Flow	$-200.0M	↑ 96.08%
Financing Cash Flow	$85.0M	↓ 144.97%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$211.0M	↓ 64.89%
Investing Cash Flow	$-130.0M	↓ 35.0%
Financing Cash Flow	$-146.0M	↓ 271.76%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$289.0M	↑ 36.97%
Investing Cash Flow	$-100.0M	↓ 23.08%
Financing Cash Flow	$358.0M	↓ 345.21%

Bausch Health Companies Technicals Summary

Sell

Neutral

Buy

Bausch Health Companies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Bausch Health Companies Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bausch Health Companies Inc	31.96%	31.13%	45.04%	53.03%	-50.56%
Haleon Plc Spon Ads	1.26%	-3.4%	-1.23%	61.37%	30.23%
United Therapeutics Corporation	6.83%	-16.01%	-10.17%	39.52%	76.09%
Zoetis Inc.	4.57%	-1.51%	-16.46%	-9.09%	-2.82%
Neurocrine Biosciences Inc.	0.81%	16.61%	-10.35%	24.21%	17.48%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bausch Health Companies Inc	32.08	32.08	0.63	3.65	-23.05	0.04	NA	-2.07
Haleon Plc Spon Ads	21.44	21.44	3.08	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	12.22	12.22	1.43	26.95	0.19	0.13	NA	158.65
Zoetis Inc.	26.53	26.53	2.49	6.32	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	39.32	39.32	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bausch Health Companies Inc	Hold	$3.1B	-50.56%	32.08	0.99%
Haleon Plc Spon Ads	Buy	$43.6B	30.23%	21.44	13.81%
United Therapeutics Corporation	Buy	$14.2B	76.09%	12.22	40.36%
Zoetis Inc.	Buy	$68.3B	-2.82%	26.53	27.83%
Neurocrine Biosciences Inc.	Buy	$13.2B	17.48%	39.32	13.88%

About Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Organization	Bausch Health Companies
Employees	20700
CEO	Mr. Thomas J. Appio
Industry	Health Technology

Key Management of Bausch Health Companies Inc

Name	Title
Mr. Thomas J. Appio	CEO & Director
Mr. Jean-Jacques Charhon	Executive VP & CFO
Ms. Seana Carson	Executive VP & General Counsel
Ms. Aimee J. Lenar	Executive Vice President of US Pharma
Mr. Mirza Dautbegovic	Executive VP & COO
Mr. Steven Lee	Senior VP, Controller & Chief Accounting Officer
Mr. Garen Sarafian	VP & Head of Investor Relations
Ms. Kathleen Fitzpatrick	Executive VP and Chief HR & Communications Officer
Mr. Cees Heiman	Senior Vice President of Europe & Canada
Ms. Jiny Kim M.B.A.	Senior Vice President of Solta Medical

Important FAQs about investing in BHC Stock from India :

What is Bausch Health Companies share price today?

Bausch Health Companies share price today is $8.04 as on August 18, 2025 at 11:45 PM IST. Bausch Health Companies share today touched a day high of $8.42 and a low of $8.00.

What is the 52 week high and 52 week low for Bausch Health Companies share?

Bausch Health Companies share touched a 52 week high of $9.85 and a 52 week low of $4.25. Bausch Health Companies stock price today, August 18, 2025 at 11:45 PM IST is trending at $8.04, lower by 18.38% versus the 52 week high.

How to invest in Bausch Health Companies Stock (BHC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bausch Health Companies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bausch Health Companies Shares that will get you 0.1866 shares as per Bausch Health Companies share price of $8.04 per share as on August 18, 2025 at 11:45 PM IST.

What is the minimum amount required to buy Bausch Health Companies Stock (BHC) from India?

Indian investors can start investing in Bausch Health Companies (BHC) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Bausch Health Companies stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Bausch Health Companies share’s latest price of $8.04 as on August 18, 2025 at 11:45 PM IST, you will get 1.2438 shares of Bausch Health Companies. Learn more about fractional shares .

What are the returns that Bausch Health Companies has given to Indian investors in the last 5 years?

Bausch Health Companies stock has given -50.56% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?